Skip to content
Search

Latest Stories

NHSE&I publishes service specification for 2021/22 CPFV advanced service

The funding from the NHS vaccination budget for flu vaccination service 2021/22 season remains at £9.58 plus the cost of the vaccine.

NHS England and NHS Improvement (NHSE&I) have confirmed for those contractors providing off-site flu vaccinations will be able to apply for a contribution towards reasonable additional costs.


Details of how to apply for such funding are yet to be published by NHSE&I, but they are expected to mirror arrangements that were in place for the 2020/21 flu season, said Pharmaceutical Services Negotiating Committee (PSNC).

NHSE&I has published the service specification for the 2021/22 Community Pharmacy Seasonal Influenza Vaccination (CPFV) Advanced Service on Monday (August 2). The document formally starts the countdown to the commencement of what is expected to be the largest ever community pharmacy flu vaccination programme on Wednesday 1st September 2021.

It has also confirmed that they are looking to have a National Protocol in place to support the flu vaccination programme for 2021/22. A national protocol has already been used by many pharmacies participating in the Covid-19 vaccination programme. It could be used by contractors as an alternative to the PGD, where they are able to make use of the skill mix flexibilities allowed by the protocol.

The final decision on authorising use of a national protocol is made by the Secretary of State for Health and Social Care. At the time of publishing this news story, a protocol has yet to be published. If a protocol is published, an announcement on this will be provided to contractors via this website.

Alastair Buxton, Director of NHS Services, PSNC said: “The Committee is disappointed that the hard work undertaken by contractors and their teams last year and the increasing costs they are experiencing in providing services has not been recognised by NHSE&I in an increase in the funding for the service this season. PSNC will continue to make the case to the NHS for increased funding for the service in future years.

“If all goes as the Government hopes, this year the flu vaccination programme will once again break records for the number of people protected against flu. Pharmacy teams played a major role in the growth in vaccinations administered last year and I know they will be keen to repeat that success in 2021/22, helping reduce the risk to individuals and supporting the wider NHS winter effort.

“This year patients are at risk from flu and Covid-19, so it is important that they are able to access relevant vaccinations as early as possible; contractors will want to ensure they offer flu vaccination to patients as soon as supplies become available."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less